Robert Iannone
Equibles does not estimate personal net worth.
Get an email with a short summary when Jazz Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get JAZZ alertsAbout Robert Iannone
The proxy statement of Jazz Pharmaceuticals plc reports total compensation of $8,661,758 for Robert Iannone in fiscal 2025, including a base salary of $793,077. Disclosed compensation is on record for 7 fiscal years. Jazz Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jazz Pharmaceuticals plc includes Bruce Cozadd (CEO and Board Member), Renee D. Gala (CEO), Renee Gala (CEO, COO and Board Member) and 7 others.
Affiliation history
-
Jazz Pharmaceuticals plc (JAZZ)
Proxy statement
CurrentStart not stated–present
Last confirmed June 14, 2024
Company network
Leadership on record at Jazz Pharmaceuticals plc
- Bruce Cozadd CEO, Board Member
- Renee D. Gala CEO
- Renee Gala CEO, COO, Board Member
- Matthew P. Young CFO
- Philip Johnson CFO
- Renée D. Galá CFO
- Chris Tovey COO
- Renée Galá COO
- Neena M. Patil General Counsel
- Patricia Carr Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $793,077 | $8,661,758 |
| 2024 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $750,692 | $5,689,377 |
| 2023 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $720,526 | $4,979,077 |
| 2022 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $663,672 | $4,855,654 |
| 2021 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | $591,923 | $4,001,336 |
| 2020 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | $592,308 | $3,149,481 |
| 2019 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | $313,077 | $3,693,560 |
Recent activity
No call appearances or filed executive changes recorded yet.